BIDOLI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 526
EU - Europa 265
AS - Asia 120
AF - Africa 12
SA - Sud America 8
OC - Oceania 2
Totale 933
Nazione #
US - Stati Uniti d'America 513
IT - Italia 84
DE - Germania 46
CN - Cina 38
FR - Francia 33
AT - Austria 25
GB - Regno Unito 15
IN - India 15
IE - Irlanda 14
HK - Hong Kong 13
TR - Turchia 13
CA - Canada 10
JP - Giappone 10
KR - Corea 7
RU - Federazione Russa 7
VN - Vietnam 7
EG - Egitto 6
FI - Finlandia 6
UA - Ucraina 6
NL - Olanda 5
TW - Taiwan 5
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 4
BR - Brasile 3
CL - Cile 3
ES - Italia 3
GH - Ghana 3
ID - Indonesia 3
HU - Ungheria 2
MX - Messico 2
RO - Romania 2
SG - Singapore 2
ZA - Sudafrica 2
AM - Armenia 1
AU - Australia 1
BN - Brunei Darussalam 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
KH - Cambogia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
Totale 933
Città #
Santa Cruz 88
Fairfield 33
Ashburn 29
Milan 25
Vienna 24
Buffalo 20
Seattle 19
Houston 17
Woodbridge 13
Beijing 12
Cambridge 12
Wilmington 11
Chicago 10
San Diego 10
Ann Arbor 9
Dublin 9
Frankfurt am Main 8
Mountain View 8
Boardman 7
Central 7
Los Angeles 7
Rome 7
Cairo 6
Helsinki 6
Provo 6
University Park 6
Dong Ket 5
Redmond 5
Toronto 5
Wuhan 5
Dallas 4
Fleming Island 4
Gangdong-gu 4
Guangzhou 4
Istanbul 4
Las Vegas 4
London 4
Naples 4
Paris 4
Shanghai 4
Taipei 4
Bolzano 3
Brooklyn 3
Clearwater 3
Kolkata 3
Saint Petersburg 3
Seoul 3
Adana 2
Amsterdam 2
Andover 2
Ankara 2
Annone di Brianza 2
Athens 2
Bacoli 2
Bengaluru 2
Bergamo 2
Bologna 2
Brussels 2
Bussolengo 2
Büdelsdorf 2
Calgary 2
Ciudad Lopez Mateos 2
Council Bluffs 2
Henderson 2
Induno Olona 2
Isparta 2
Jakarta 2
Kansas City 2
Madison 2
Meerut 2
Molesey 2
Muizenberg 2
Mumbai 2
Nellore 2
Oklahoma City 2
Palo Alto 2
Portland 2
Princeton 2
Reston 2
Riva 2
San Francisco 2
Scranton 2
Singapore 2
Szigethalom 2
São Paulo 2
Tokyo 2
Winston-Salem 2
Ōita 2
Aisai 1
Algiers 1
Alpignano 1
Archanes 1
Atlanta 1
Auburn 1
Austin 1
Avellino 1
Bagnacavallo 1
Bandung 1
Bitola 1
Bochum 1
Totale 585
Nome #
Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab, file e39773b7-8650-35a3-e053-3a05fe0aac26 193
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma, file e39773b6-5ef4-35a3-e053-3a05fe0aac26 155
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose, file e39773b2-26d7-35a3-e053-3a05fe0aac26 84
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study., file e39773b4-fce4-35a3-e053-3a05fe0aac26 80
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer, file e39773b7-8fb9-35a3-e053-3a05fe0aac26 63
Liquid biopsy testing can improve selection of advanced non-small-cell lung cancer patients to rechallenge with gefitinib, file e39773b7-864d-35a3-e053-3a05fe0aac26 62
Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer, file e39773b7-864c-35a3-e053-3a05fe0aac26 59
Focus on nivolumab in NSCLC, file e39773b7-8fbb-35a3-e053-3a05fe0aac26 49
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations, file e39773b7-864f-35a3-e053-3a05fe0aac26 46
Second-line erlotinib or intermittent erlotinib plus docetaxel in male ex-smokers with squamous NSCLC: The TALISMAN randomized trial, file e39773b7-8651-35a3-e053-3a05fe0aac26 45
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer, file e39773b7-8fba-35a3-e053-3a05fe0aac26 45
Novel cytotoxic chemotherapies in small cell lung carcinoma, file e39773b7-6dd6-35a3-e053-3a05fe0aac26 43
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)], file 69ec8715-4f64-4345-8137-8ee898490b78 11
A new race against lung cancer, file b077a8ac-a243-4e80-8a91-360d9865975d 6
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial, file d1eff57f-dde1-430c-9051-a81a74929618 2
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial, file e39773b6-4d56-35a3-e053-3a05fe0aac26 2
Radiologic examination in assessing the response to chemoradiotherapy of esophageal spinocellular carcinoma, file e39773b5-dedf-35a3-e053-3a05fe0aac26 1
Small cell lung cancer, file e39773b5-dee2-35a3-e053-3a05fe0aac26 1
Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial, file e39773b5-f087-35a3-e053-3a05fe0aac26 1
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer, file e39773b5-f1e2-35a3-e053-3a05fe0aac26 1
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial, file e39773b5-fa8a-35a3-e053-3a05fe0aac26 1
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients, file e39773b6-03bc-35a3-e053-3a05fe0aac26 1
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study, file e39773b6-2b2f-35a3-e053-3a05fe0aac26 1
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer, file e39773b6-2d38-35a3-e053-3a05fe0aac26 1
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial, file e39773b8-5979-35a3-e053-3a05fe0aac26 1
Totale 954
Categoria #
all - tutte 2.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 4 4 3 3 4
2019/202028 3 0 3 3 0 1 2 8 0 3 4 1
2020/2021110 3 7 2 2 7 3 5 2 16 28 15 20
2021/2022275 10 10 11 16 21 16 17 12 12 24 87 39
2022/2023335 28 32 74 52 9 11 21 24 18 23 27 16
2023/2024143 6 15 16 18 27 28 20 13 0 0 0 0
Totale 954